Physician profile
Daphne A Lambert
NPI 1497122113
$451.49
in general payments reported to CMS, 2019-2025
9 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.29 · 2022: $41.65 · 2023: $97.02 · 2024: $113 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $117.84 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $78.05 | 2024-2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $77.61 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $59.24 | 2022-2023 | Trelegy Ellipta |
| Abbott Laboratories | $49.90 | 2024-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $24.16 | 2025 | Breztri |
| E.R. Squibb & Sons, L.L.C. | $15.65 | 2022 | |
| Pfizer INC. | $15.29 | 2021 | |
| Abbvie INC. | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.